The Safety and Feasibility of Radiofrequency Ablation to Treat Low-risk Thyroid Cancer

The goal of this clinical trial is to test radiofrequency ablation (RFA) in thyroid cancers ≤2 cm in diameter. The main question it aims to answer is: • What is the feasibility of RFA use for low-risk thyroid cancers (≤2 cm)? Participants will undergo a set of pre-procedural scans of the target thyroid nodule and undergo the RFA procedure/intervention. Then, participants will partake in three follow-up appointments at 4 weeks, 6 months, and 12 months post-procedure as per standard of care.

Trial Details

NCT ID
NCT06929650
Phase
NA
Sponsor
University Health Network, Toronto
Status
RECRUITING
Cancer Type
Thyroid Cancer
Interventions
  • Radiofrequency ablation
Locations (sample)
  • Toronto, Ontario, Canada|43.65333,-79.38389

Key Eligibility Criteria

  • 1\. Patients with:
  • Nodule less than or equal to 2cm in size
  • a. Specifically: Bethesda 5/6
  • Their age is ≥18 years and ≤100 years

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Thyroid Cancer Trials on Trialify →